Clinical Trial: The Impact of the 2025 Infant and Maternal Respiratory Syncytial Virus (RSV) Prevention Program on RSV-related Hospitalisations in the Australian Capital Territory

U.S., Sept. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07164430) titled 'The Impact of the 2025 Infant and Maternal Respiratory Syncytial Virus (RSV) Prevention Program on RSV-related Hospitalisations in the Australian Capital Territory' on Sept. 04.

Brief Summary: The goal of this observational study is to is to examine the impact of new RSV prevention medicines on the burden of RSV disease among young children. The main question it aims to answer is:

What was the impact of the 2025 RSV prevention program on RSV-related hospitalisation in children under 2 years of age?

Participants won't need to do anything additional for the study as only routinely collected health information will be used to answer...